Tag Archives: peptide medicine

Peptides Rally: What’s New on the Regulatory Landscape for the Body’s Super Signalers

Peptides Rally: What’s New on the Regulatory Landscape for the Body’s Super Signalers

Peptides are powerhouses, the body’s versatile amino chains that play a part in tissue repair, hormone release, collagen production, metabolism optimization, infection fighting, and so much more. Yet even as science uncovers myriad therapeutic and cosmetic applications for these microscopic miracle workers, peptides remain highly regulated. That may be about to change.

An FDA advisory panel is set to meet in late July to determine the fate of seven peptides that are now restricted due to safety concerns, possibly expanding access and allowing compounding that will make the health and anti-aging properties of peptides legally available in the US. The FDA will also review five additional peptides by early 2027, and approvals are expected to pave the way for exciting breakthroughs in the health and longevity community.

Continue reading

Mapping The Longevity Blueprint: Peptide Therapies

“The current use of peptides is everything you can think of. From antimicrobial, antioxidant, and anti-obesity uses, to hormone regulation, dyslipidemia, digestion, and cognitive performance enhancement. Virtually every bodily function you can think of utilizes peptides.” James LaValle, RPh, CCN, MT, DHM, DHPh, A4M Scientific Planning Committee and IPS Steering Committee Chair 

The mapping of the human longevity blueprint has launched a new era of research into peptide therapies for precision life extension. Groundbreaking peptide advances welcome a coming age in which the root causes of aging may be targeted, optimized, and potentially reversed – expanding the boundaries of the human lifespan. This paradigm shift represents a transition from reactive to proactive aging management, addressing fundamental age-related decline rather than downstream effects alone.

Today, there are over 90 FDA-approved peptide therapeutics with over 150 in clinical development and up to 600 undergoing preclinical trials. In medical practices across the globe, peptide therapies are being used to help treat cancer, infectious diseases, metabolic disorders, injuries, and much more.

Research continues to unveil the power of peptide therapies for disease management, performance optimization, and longevity strategies.

Continue reading